Because hospital patients often have to stay in bed for long periods of time, all patients admitted to the hospital are at increased risk of developing blood clots in their veins (also called venous thromboembolism, or VTE) that can break off and travel to other parts of the body, like the heart, brain, or lung.
Hospitals can prevent blood clots by routinely evaluating patients for their risk of developing blood clots and using appropriate prevention and treatment procedures. Prevention can include compression stockings, blood thinners, and/or other medicines.
This measure shows the percentage of patients who received treatment to prevent blood clots:
Patients who did not receive treatment may also be included in this measure, if they had paperwork in their chart to explain why. Reasons for not receiving treatment may include having a massive wound, actively bleeding, or having an allergy to blood thinners.
Patients in the Intensive Care Unit (ICU) are at increased risk for developing blood clots in their veins (venous thromboembolism, or VTE), because they are in bed for a long period of time. These clots can break off and travel to other parts of the body, causing serious harm.
Hospitals can prevent blood clots by routinely evaluating all patients for their risk of developing blood clots and using appropriate prevention and treatment procedures. Prevention can include compression stockings, blood thinners, and/or other medicines.
This measure shows the percentage of ICU patients who received treatment to prevent blood clots:
Patients who did not receive treatment may also be included in this measure, if they had paperwork in their chart to explain why. Reasons for not receiving treatment may include having a massive wound, actively bleeding, or having an allergy to blood thinners.
Because hospital patients often have to stay in bed for long periods of time, all patients admitted to the hospital are at increased risk of developing blood clots in their veins (also called venous thromboembolism or VTE) that can break off and travel to other parts of the body, like the heart, brain, or lung.
Hospitals can prevent blood clots by routinely evaluating patients for their risk of developing blood clots and using appropriate prevention and treatment procedures. Prevention can include compression stockings, blood thinners, and/or other medicines.
This measure shows the percentage of patients who developed blood clots while in the hospital who did not receive preventative treatment beforehand.
Patients who develop blood clots in their veins (also called venous thromboembolism, or VTE) need to get treatment that can break up the clots quickly and prevent others from forming.
The recommended treatment is to first give a blood thinner that can get into the bloodstream quickly through an IV or injection (heparin), then give a slower-acting oral blood thinner medicine (warfarin), and continue giving both blood thinners for 5 days or until it is safe for the patient to transition off of the IV blood thinner and use only the oral blood thinner medicine.
This measure shows the percentage of hospital patients who had a confirmed diagnosis of blood clot at hospital admission or during their hospital stay, and received both medicines for at least 5 days, or were discharged from the hospital on both kinds of medicine, unless their blood work showed they no longer needed it.
Patients who develop blood clots (also called venous thromboembolism or VTE) will usually be given blood thinner medicines to take when they leave the hospital.
Educating patients about how to take the medicine and its possible side effects can help prevent problems that could bring them back to the hospital. Before leaving the hospital, patients with a blood clot, who are taking a blood thinner medicine, and their caregiver should receive information about the following topics:
This measure shows the percentage of patients diagnosed with a blood clot (either at admission or during their hospital stay) discharged from the hospital on blood thinners (anticoagulants or anticoagulant therapy or warfarin therapy) who received written educational instructions at hospital discharge.
All descriptions and data sources are reported from Hospital Compare.
Data reported are based on discharges from First Quarter 2013 through Third Quarter 2013